Tian Du,

Tian Du is a news reporter who focuses on the intersection of technology and society. With a background in computer science and journalism, Tian covers topics such as artificial intelligence, cybersecurity, and the impact of technology on human rights. In their reporting, Tian has exposed conflicts of interest within major tech companies and highlighted the ways in which technology is being used to suppress free speech and undermine democratic processes. Through their investigative pieces, Tian has also uncovered instances of deceptive practices within the industry, including data manipulation and misleading advertising. Tian's work often emphasizes the importance of holding tech companies accountable for their actions and promoting transparency in an increasingly digital world.

100%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Discovery of Heparinoids as Effective Antidote for Cobra Venom: A Potential Solution to Snakebite-Related Disability and Deaths

New Discovery of Heparinoids as Effective Antidote for Cobra Venom: A Potential Solution to Snakebite-Related Disability and Deaths

Broke On: Thursday, 18 July 2024 Scientists from the University of Sydney, Liverpool School of Tropical Medicine, and Instituto Clodomiro Picado discover heparinoids, a class of drugs commonly used as blood thinners, can protect human cells from cobra venom's tissue-damaging toxins. Through CRISPR gene editing technology, they identified that injecting tinzaparin into mice with artificial snakebites reduced tissue damage. If successful in human trials, this could lead to the creation of an affordable and quickly distributable snakebite treatment device containing heparin-like drugs.